Molecular targeted therapy: Treating cancer with specificity

被引:790
作者
Lee, Yeuan Ting [1 ]
Tan, Yi Jer [1 ]
Oon, Chern Ein [1 ]
机构
[1] Univ Sains Malaysia, Inst Res Mol Med INFORMM, George Town, Malaysia
关键词
Molecular targeted therapy; Cancer; Small molecule; Monoclonal antibody; Therapeutic cancer vaccine; Gene therapy; MONOCLONAL-ANTIBODIES; BREAST-CANCER; TYROSINE KINASE; INHIBITOR; CHEMOTHERAPY; MECHANISMS; RESISTANCE; DISCOVERY; APOPTOSIS; CELLS;
D O I
10.1016/j.ejphar.2018.07.034
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Molecular targeted therapies are revolutionized therapeutics which interfere with specific molecules to block cancer growth, progression, and metastasis. Many molecular targeted therapies approved by the Food and Drug Administration (FDA), have demonstrated remarkable clinical success in the treatment of a myriad of cancer types including breast, leukemia, colorectal, lung, and ovarian cancers. This review provides an update on the different types of molecular targeted therapies used in the treatment of cancer, focusing on the fundamentals of molecular targeted therapy, its mode of action in cancer treatment, as well as its advantages and limitations.
引用
收藏
页码:188 / 196
页数:9
相关论文
共 100 条
[1]   A developed antibody-drug conjugate rituximab-vcMMAE shows a potent cytotoxic activity against CD20-positive cell line [J].
Abdollahpour-Alitappeh, Meghdad ;
Karouei, Seyed Masoud Hashemi ;
Lotfinia, Majid ;
Amanzadeh, Amir ;
Habibi-Anbouhi, Mahdi .
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2018, 46 :1-8
[2]  
Abramson R., 2017, OVERVIEW TARGETED TH
[3]  
Amer Magid H, 2014, Mol Cell Ther, V2, P27
[4]  
[Anonymous], ISRN BIOCH
[5]  
[Anonymous], BIOL THER CANC
[6]  
[Anonymous], FDA APPR PAZ HYDR
[7]  
[Anonymous], 2015, BIOMEDICINE
[8]  
[Anonymous], TARG CANC THER
[9]   Management of treatment-associated toxicites of anti-angiogenic therapy in patients with brain tumors [J].
Armstrong, Terri S. ;
Wen, Patrick Y. ;
Gilbert, Mark R. ;
Schiff, David .
NEURO-ONCOLOGY, 2012, 14 (10) :1203-1214
[10]   Tyrosine kinase inhibitors and multidrug resistance proteins: interactions and biological consequences [J].
Azzariti, Amalia ;
Porcelli, Letizia ;
Simone, Grazia M. ;
Quatrale, Anna E. ;
Colabufo, Nicola A. ;
Berardi, Francesco ;
Perrone, Roberto ;
Zucchetti, Massimo ;
D'Incalci, Maurizio ;
Xu, Jian Ming ;
Paradiso, Angelo .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (02) :335-346